Cargando…

Clinical significance of T cell metabolic reprogramming in cancer

Conversion of normal cells to cancer is accompanied with changes in their metabolism. During this conversion, cell metabolism undergoes a shift from oxidative phosphorylation to aerobic glycolysis, also known as Warburg effect, which is a hallmark for cancer cell metabolism. In cancer cells, glycoly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herbel, Christoph, Patsoukis, Nikolaos, Bardhan, Kankana, Seth, Pankaj, Weaver, Jessica D., Boussiotis, Vassiliki A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980327/ https://www.ncbi.nlm.nih.gov/pubmed/27510264 http://dx.doi.org/10.1186/s40169-016-0110-9

Ejemplares similares

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses
por: Patsoukis, Nikolaos, et al.
Publicado: (2017)

PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
por: Patsoukis, Nikolaos, et al.
Publicado: (2015)

Effects of PD-1 Signaling on Immunometabolic Reprogramming
por: Boussiotis, Vassiliki A., et al.
Publicado: (2022)

Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2019)

Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2020)

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
por: Bardhan, Kankana, et al.
Publicado: (2016)

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
por: Le Bourgeois, Thibault, et al.
Publicado: (2018)

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
por: Christofides, Anthos, et al.
Publicado: (2016)

T Cell Metabolism in Cancer Immunotherapy
por: Aksoylar, Halil-Ibrahim, et al.
Publicado: (2020)

Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
por: Li, Lequn, et al.
Publicado: (2012)

Revisiting the PD-1 pathway
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Epigenetics and Colorectal Cancer Pathogenesis
por: Bardhan, Kankana, et al.
Publicado: (2013)

Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)
por: Sari-Ak, Duygu, et al.
Publicado: (2022)

Rap1-interacting adapter molecule (RIAM) associates with the plasma membrane via a proximity detector
por: Wynne, Joseph P., et al.
Publicado: (2012)

Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Commentary on: Combination of Metabolic Intervention and T Cell Therapy Enhances Solid Tumor Immunotherapy
por: Christofides, Anthos, et al.
Publicado: (2021)

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance
por: Chen, Xun, et al.
Publicado: (2020)

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease
por: Tijaro-Ovalle, Natalia M., et al.
Publicado: (2019)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Blockade of 6-phosphogluconate dehydrogenase generates CD8(+) effector T cells with enhanced anti-tumor function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
por: Karantanos, Theodoros, et al.
Publicado: (2017)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function
por: Daneshmandi, Saeed, et al.
Publicado: (2021)

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance
por: Nagao, Ayako, et al.
Publicado: (2019)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
por: Ibis, Betul, et al.
Publicado: (2023)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Metabolic reprogramming and its clinical application in thyroid cancer
por: Wen, Shi-Shuai, et al.
Publicado: (2019)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Mutations in NDUFS1 Cause Metabolic Reprogramming and Disruption of the Electron Transfer
por: Ni, Yang, et al.
Publicado: (2019)

Role of Glucose Metabolism Reprogramming in the Pathogenesis of Cholangiocarcinoma
por: Pant, Kishor, et al.
Publicado: (2020)

Metabolic Reprogramming and Vulnerabilities in Cancer
por: Lyssiotis, Costas A., et al.
Publicado: (2019)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

The evolving role of tissue-resident memory T cells in infections and cancer
por: Yenyuwadee, Sasitorn, et al.
Publicado: (2022)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Editorial: Cell Stress, Metabolic Reprogramming, and Cancer
por: Giannattasio, Sergio, et al.
Publicado: (2018)

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
por: Shukla, Surendra K, et al.
Publicado: (2014)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j97nl9vdsgq7pl3toe59nl5tpa